Skip to content
Screener

Globus Medical GMED Payments for Repurchase of Common Stock

Payments for Repurchase of Common Stock at other companies

Medtronic logo
MedtronicMDT
——
CONMED logo
CONMEDCNMD
——

Other financials

Income statement

See full
Revenue$789.6M+5.9%
Gross profit$548.2M+10.4%
Operating income$182.4M+140%
Net income$151.6M-25.3%
EPS (diluted)$1.10-26.2%

Balance sheet

See full
Cash & equivalents$507.7M+121%
Total debt$112.3M-7.6%
Total equity$4.8B+11.0%
Total assets$5.5B+10.6%

Cash flow

See full
Operating cash flow$209.7M+169%
CapEx$33.2M-28.8%
Free cash flow$176.6M+464%

Valuation

See full
Market cap$11.01B+53.9%
Enterprise value$10.61B+50.6%
P/E20.6×+0.5×
P/S3.5×+0.8×

Profitability

See full
Gross margin68.5%+5.8pp
Operating margin20.3%+9.6pp
Net margin17%+3.4pp
FCF margin24%+3.9pp

Returns & leverage

See full
Return on equity11.8%+3.2pp
Debt / equity0×0.0×
Current ratio4.6×+0.5×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The source filing: Globus Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054450
(In thousands)Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Payment of business acquisition-related liabilities(13,720)(7,864)
Net proceeds from exercise of stock options36,93215,920
Payments related to tax withholdings for share-based compensation(3,453)(2,953)
Repurchase of common stock(136,058)(215,451)
Repayment of senior convertible notes—(449,985)
Net cash provided by/(used in) financing activities(116,299)(660,333)
Effect of foreign exchange rates on cash(2,495)17,899
Net increase/(decrease) in cash and cash equivalents(18,411)(554,992)

Item 1. Financial Statements

FAQ

What is Globus Medical's payments for repurchase of common stock?
Globus Medical (GMED) reported payments for repurchase of common stock of $136.06M in Q2 2026.
How has Globus Medical's payments for repurchase of common stock changed year-over-year?
Globus Medical's payments for repurchase of common stock increased by 444.2% year-over-year, from $25M to $136.06M.
What is the long-term trend for Globus Medical's payments for repurchase of common stock?
Over 3 years (2022 to 2025), Globus Medical's payments for repurchase of common stock has grown at a 27.6% compound annual growth rate (CAGR), from $144.49M to $300.45M.
What does payments for repurchase of common stock mean?
Payments for Repurchase of Common Stock

Ask your AI about Globus Medical's payments for repurchase of common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude